Centerpiece
Click for Full Story Pharma M&A slowdown?

A government crackdown on a financial maneuver used by U.S. companies to slash their tax bill will likely cause merger activity in the pharmaceutical industry to halve to around $200 billion annually, according to one estimate.

  1 of 5 
Read Story Apr. 30, 2016
Click for Full Story Earnings halftime report Apr. 29, 2016
 
Click for Full Story Falling revenue, rising stock Apr. 28, 2016
 
Click for Full Story Coke's new cans Apr. 27, 2016
 
Click for Full Story Time for used car deals Apr. 26, 2016
 
Latest Headlines
Quote
Spotlight
Click for Full Story Exxon’s profit plunges

Exxon Mobil recorded its weakest quarter in more than 16 years as lower oil prices pushed its profit down 63 percent.

  1 
Read Story Apr. 30, 2016



AP Privacy Policy | AP Terms of Use